Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $26.8000 (3.08%) ($26.0000 - $26.8800) on Thu. Sep. 22, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.04% (three month average) | RSI | 50 | Latest Price | $26.8000(3.08%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EYES declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(7%) UUP(6%) ICLN(5%) ARKK(4%) DIA(4%) | Factors Impacting EYES price | EYES will decline at least -2.02% in a week (0% probabilities). BND(-7%) BNDX(-5%) XLU(-4%) XLP(-4%) VCSH(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.02% (StdDev 4.04%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
1 - 5 Day Possible Target | $22.17(-17.28%) | 5 Day Moving Average | $26.18(2.37%) | 10 Day Moving Average | $26.34(1.75%) | 20 Day Moving Average | $26.7(0.37%) | To recent high | -21% | To recent low | 5.3% | Market Cap | $8.56b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |